Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study

This article was originally published in The Tan Sheet

Executive Summary

Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine

You may also be interested in...

Low-Dose Aspirin Safety, CVD Efficacy “Superior” To Higher Doses – McNeil

Low-dose aspirin in the range of 81 mg-162 mg has a superior bleeding profile and similar efficacy to higher OTC doses for cardiovascular protection, Eric Topol, MD, Cleveland Clinic Foundation, told the FDA's Nonprescription Drugs Advisory Committee

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts